385 related articles for article (PubMed ID: 15948980)
1. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations.
Sun A; Chang YF; Chia JS; Chiang CP
J Oral Pathol Med; 2004 Mar; 33(3):133-9. PubMed ID: 15128054
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
[TBL] [Abstract][Full Text] [Related]
4. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
Sun A; Chia JS; Wang JT; Chiang CP
Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
[TBL] [Abstract][Full Text] [Related]
5. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
6. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152
[TBL] [Abstract][Full Text] [Related]
7. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
Wu KM; Wang YP; Lin HP; Chen HM; Chia JS; Sun A
J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020
[TBL] [Abstract][Full Text] [Related]
8. Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus.
Chang JY; Chiang CP; Hsiao CK; Sun A
J Oral Pathol Med; 2009 Jan; 38(1):48-54. PubMed ID: 18764857
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone.
Rhodus NL; Cheng B; Bowles W; Myers S; Miller L; Ondrey F
Oral Dis; 2006 Mar; 12(2):112-6. PubMed ID: 16476030
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression in oral lichen planus.
Zhou ZT; Wei BJ; Shi P
J Oral Pathol Med; 2008 Feb; 37(2):94-8. PubMed ID: 18197854
[TBL] [Abstract][Full Text] [Related]
11. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2003 Apr; 32(4):206-14. PubMed ID: 12653859
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients.
Rhodus NL; Cheng B; Myers S; Bowles W; Ho V; Ondrey F
Clin Immunol; 2005 Mar; 114(3):278-83. PubMed ID: 15721838
[TBL] [Abstract][Full Text] [Related]
13. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.
Rhodus NL; Cheng B; Ondrey F
Mediators Inflamm; 2007; 2007():19854. PubMed ID: 17497029
[TBL] [Abstract][Full Text] [Related]
14. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
Lin HP; Wang YP; Chia JS; Sun A
J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
[TBL] [Abstract][Full Text] [Related]
15. Investigation of functional gene polymorphisms interleukin-1beta, interleukin-6, interleukin-10 and tumor necrosis factor in individuals with oral lichen planus.
Xavier GM; de Sá AR; Guimarães AL; da Silva TA; Gomez RS
J Oral Pathol Med; 2007 Sep; 36(8):476-81. PubMed ID: 17686006
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus.
Sklavounou-Andrikopoulou A; Chrysomali E; Iakovou M; Garinis GA; Karameris A
J Oral Pathol Med; 2004 Aug; 33(7):386-90. PubMed ID: 15250829
[TBL] [Abstract][Full Text] [Related]
17. Oral and serum IL-6 levels in oral lichen planus patients.
Gu GM; Martin MD; Darveau RP; Truelove E; Epstein J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):673-8. PubMed ID: 15583539
[TBL] [Abstract][Full Text] [Related]
18. Salivary levels of tumor necrosis factor-alpha in oral lichen planus.
Pezelj-Ribaric S; Prso IB; Abram M; Glazar I; Brumini G; Simunovic-Soskic M
Mediators Inflamm; 2004 Apr; 13(2):131-3. PubMed ID: 15203556
[TBL] [Abstract][Full Text] [Related]
19. A clinical study of 674 patients with oral lichen planus in China.
Xue JL; Fan MW; Wang SZ; Chen XM; Li Y; Wang L
J Oral Pathol Med; 2005 Sep; 34(8):467-72. PubMed ID: 16091113
[TBL] [Abstract][Full Text] [Related]
20. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
